Managed Care
Disease
Management

With Cost Study, Group Argues For OTC Benefit

MANAGED CARE August 2000. © MediMedia USA
News and Commentary

With Cost Study, Group Argues For OTC Benefit

MANAGED CARE August 2000. ©2000 MediMedia USA

A study by HECON Associates, a Maryland-based market research group, supports the claim that when prescription drugs become available over the counter, consumers face increased out-of-pocket costs.

The study focused on four drugs that recently became available over the counter. Researchers compared OTC costs with what consumers would pay in a mixed managed care/ indemnity plan (such as a private PPO), a typical HMO, and Maryland's Medicaid program. Sharp increases in out-of-pocket expenses were seen when products went to OTC status, due to the lack of an OTC drug benefit: As much as 113 percent in the managed care/indemnity plan, 233 percent in the HMO, and 9,000 percent for the Medicaid group, whose average pharmacy copayment was 13 cents.

Meetings

Medical Devices Summit Boston, MA February 19–20, 2015
3rd Annual Summit to Improve Adherence and Enhance Patient Engagement Philadelphia, PA March 9–10, 2015
Value-Added Solutions for Enhanced Customer Experience Philadelphia, PA March 9, 2015